HC, the Exclusive Financial Advisor to Hikma PLC on its Acquisition of EIMC United Pharmaceuticals S.A.E.

March 23rd, 2016 – HC Securities & Investment (www.hc-si.com) has successfully acted as the exclusive financial advisor to Hikma PLC (LSE: HIK) (NASDAQ Dubai: HIK) (Hikma), the fast growing multinational pharmaceutical group (www.hikma.com) on the acquisition of 97.7% of the share capital of EIMC United Pharmaceuticals S.A.E. (EUP) (http://www.eimcunited.com); the Egyptian pharmaceutical company, for 300 million Egyptian Pounds.

Hikma is a fast growing multinational pharmaceutical group focused on developing, manufacturing and marketing a broad range of both branded and non-branded generic and in-licensed products. Hikma’s operations are conducted through three businesses; namely, Branded, Injectables and Generics. Hikma is based principally in the Middle East and North Africa (MENA) region, where it is a market leader, as well as the United States and Europe. In 2015, Hikma achieved revenues of USD 1.4 billion and profit attributable to shareholders of USD 252 million.

EIMC United Pharmaceuticals was established in 2004 as the first Egyptian pharmaceutical company specializing in oncology and intensive care products. EUP has a robust product portfolio and a strong pipeline of products under registration. The company has a manufacturing facility at Badr Industrial City with production capabilities across different forms.

The acquisition of EIMC United Pharmaceuticals marks the third acquisition for Hikma in Egypt. This acquisition will further support Hikma in achieving its strategy of growing presence in Egypt, as a key market in the MENA region, as well as penetrate the growing oncology therapeutic segment.

HC Securities & Investment previously advised Hikma on the acquisition of 100% of Egyptian Company for Pharmaceuticals & Chemical Industries (EPCI) in 2013.

Noha El Ghazaly, Executive Director – Investment Banking at HC Securities and Investment, commented on the transaction, “We are proud of our continuous success in supporting our clients in the MENA region across different sectors. This is our second M&A transaction to close in 2016 where we remain confident in the fundamental strengths of the Egyptian market to attract investments from strategic and financial investors.”